Equities Analysts Issue Forecasts for Bruker FY2027 Earnings

Bruker Co. (NASDAQ:BRKR) – Analysts at Zacks Research raised their FY2027 earnings estimates for Bruker in a research report issued on Tuesday, March 11th. Zacks Research analyst R. Department now expects that the medical research company will post earnings per share of $3.61 for the year, up from their prior forecast of $3.60. The consensus estimate for Bruker’s current full-year earnings is $2.69 per share.

Bruker (NASDAQ:BRKR) last announced its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%.

A number of other equities analysts have also issued reports on BRKR. Barclays dropped their target price on shares of Bruker from $69.00 to $65.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. UBS Group began coverage on shares of Bruker in a research note on Tuesday, December 10th. They issued a “neutral” rating and a $66.00 price objective for the company. Guggenheim restated a “buy” rating on shares of Bruker in a research note on Monday, February 24th. Bank of America increased their price objective on shares of Bruker from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Friday, December 13th. Finally, Stifel Nicolaus dropped their price objective on shares of Bruker from $70.00 to $57.00 and set a “hold” rating for the company in a research note on Friday, February 14th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $70.50.

Bruker Trading Down 1.3 %

Shares of BRKR stock opened at $44.96 on Thursday. Bruker has a 1 year low of $44.82 and a 1 year high of $94.86. The firm’s fifty day simple moving average is $54.21 and its 200 day simple moving average is $58.66. The firm has a market capitalization of $6.82 billion, a P/E ratio of 59.16, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15.

Institutional Investors Weigh In On Bruker

A number of hedge funds have recently added to or reduced their stakes in BRKR. True Wealth Design LLC grew its holdings in Bruker by 4,636.4% during the 3rd quarter. True Wealth Design LLC now owns 521 shares of the medical research company’s stock worth $36,000 after acquiring an additional 510 shares during the last quarter. Eagle Bay Advisors LLC boosted its stake in shares of Bruker by 2,324.1% in the 4th quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock valued at $41,000 after purchasing an additional 674 shares during the last quarter. UMB Bank n.a. boosted its stake in shares of Bruker by 37.5% in the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock valued at $53,000 after purchasing an additional 248 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Bruker by 47.5% in the 4th quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company’s stock valued at $75,000 after purchasing an additional 412 shares during the last quarter. Finally, Quadrant Capital Group LLC boosted its stake in shares of Bruker by 18.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,273 shares of the medical research company’s stock valued at $75,000 after purchasing an additional 196 shares during the last quarter. Institutional investors own 79.52% of the company’s stock.

Bruker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Shareholders of record on Monday, March 17th will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend is Monday, March 17th. Bruker’s dividend payout ratio is currently 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.